As the premier bio-convergence company, CELLINK is creating the future of medicine by providing biomedical technologies, products and services to life science researchers around the world. Whether you are setting up complicated combinatorial screening, running next generation sequencing workflows or assuring monoclonality for cell line development and synthetic biology, our Biosciences division has you covered.
Our single-cell-dispensers have a fast and gentle method to clone single cells after transfection into a gene editing workflow while maintaining traceability of individual clones at all times. Gentle handling is key because the viability of post transfected cells is often compromised and therefore they are compatible for use in gene editing and cell therapy. As a result, they can be used to meet the requirements of medical therapies for the use of genetically modified cells in many medical applications.